#drug-price-negotiation

#drug-price-negotiation

Medicare Drug Price Negotiation Program faces legal challenges from pharmaceutical companies, impacting access to medicines.

Court rulings affirm that claims against the program lack merit as participation is voluntary and not regulatory.